Turnover of domestic pharmaceutical firms up 8% in first quarter

Published: 2002-05-22 07:00:00

Updated: 2002-05-22 07:00:00

The combined turnover of the 22 major domestic pharmaceutical firms (except for Korea Green Cross, Chong Kun Dang Corp., and Chong Kun Dang Bio) in the first quarter of this year marked 629.9 billion won, representing a sluggish growth rate of 8.71 percent from the same period of last year, accor...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK